- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | HLTH Europe 2026: obesity drugs shift the paradigm, but systemic implementation lags | ||
| Di | Cystic Fibrosis Foundation backs Israeli biotech with $13m to develop inhaled drug | ||
| Di | FDA and MHRA forge new regulatory collaboration initiative | ||
| Di | Alkermes' alixorexton secures FDA and EC orphan designations | ||
| Di | ALK's EURneffy secures MHRA approval for anaphylaxis treatment | ||
| Mo | Younger UK children to benefit from new dose of nasal spray allergy drug | ||
| Mo | FDA oncology roundup: drugs, imaging agents and diagnostics gain approval | ||
| Mo | Simcere and Stanford partner to develop IPF therapies | ||
| Mo | FDA clears MSD's Keytruda combo plus Welireg for ccRCC treatment | ||
| Fr | Novo Nordisk comeback stirs as Wegovy pill wins UK approval | ||
| Fr | China's NMPA approves Akeso's gumokimab for plaque psoriasis | ||
| Fr | FDA grants priority review for Roche's Tecentriq combo sBLA | ||
| Do | Drug developers eye sport's biggest stage as World Cup fever builds | ||
| Do | XtalPi enters $400m partnership for small molecule therapy for GPCR target | ||
| Do | Beren pockets $300m to take Niemann-Pick disease therapy to market | ||
| Do | EMA validates Bayer's asundexian application for ischaemic stroke | ||
| 10.06. | Parabilis Medicines sets biotech record with $670m IPO | ||
| 10.06. | Eli Lilly continues dealmaking roll with $1bn AlzeCure agreement | ||
| 10.06. | Aditxt and Ignite announce merger plans with strategic partner | ||
| 10.06. | MHRA to roll out new AI sandbox for medicines development | ||
| 09.06. | WuXi AppTec hits back after being named in Pentagon's Chinese military list | ||
| 09.06. | GSK doubles down on oncology with $10.6bn Nuvalent takeover | ||
| 09.06. | J&J to acquire Firefly Bio for $1bn to enhance oncology pipeline | ||
| 09.06. | Pfizer's Hympavzi secures FDA expanded indications for haemophilia | ||
| 09.06. | J&J secures extended NICE approval for Darzalex following earlier refusal |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.